Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers
- PMID: 20357999
- PMCID: PMC2844609
- DOI: 10.3346/jkms.2010.25.4.564
Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers
Abstract
Transforming growth factor (TGF)-beta1 is a key cytokine producing extracellular matrix. We evaluated the effect of TGF-beta1 gene polymorphism at codon 10 on the development of cirrhosis in patients with chronic hepatitis B. One hundred seventy eight patients with chronic hepatitis (CH, n=57) or liver cirrhosis (LC, n=121), who had HBsAg and were over 50 yr old, were enrolled. The genotypes were determined by single strand conformation polymorphism. There were no significant differences in age and sex ratio between CH and LC groups. HBeAg positivity and detection rate of HBV DNA were higher in LC than in CH groups (P=0.055 and P=0.003, respectively). There were three types of TGF-beta1 gene polymorphism at codon 10: proline homozygous (P/P), proline/leucine heterozygous (P/L), and leucine homozygous (L/L) genotype. In CH group, the proportions of P/P, P/L, and L/L genotype were 32%, 51%, and 17%, respectively. In LC group, the proportions of those genotypes were 20%, 47%, and 33%, respectively. The L/L genotype was presented more frequently in LC than in CH groups (P=0.017). Multivariate logistic regression analysis confirms that detectable HBV DNA (odds ratio [OR]: 3.037, 95% confidence interval [CI]: 1.504-6.133, P=0.002) and L/L genotype (OR: 3.408, 95% CI: 1.279-9.085, P=0.014) are risk factors for cirrhosis.
Keywords: Hepatitis B Virus; Liver Cirrhosis; Polymorphism; Transforming Growth Factor beta1.
Figures


Similar articles
-
Genetic polymorphism at codon 10 of the transforming growth factor-β1 gene in patients with alcoholic liver cirrhosis.Korean J Hepatol. 2011 Mar;17(1):37-43. doi: 10.3350/kjhep.2011.17.1.37. Korean J Hepatol. 2011. PMID: 21494076 Free PMC article. Clinical Trial.
-
Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2. Infect Genet Evol. 2014. PMID: 25281206
-
Different pre-S deletion patterns and their association with hepatitis B virus genotypes.World J Gastroenterol. 2016 Sep 21;22(35):8041-9. doi: 10.3748/wjg.v22.i35.8041. World J Gastroenterol. 2016. PMID: 27672298 Free PMC article.
-
Association of IL-6, IL-10 and TGF-β1 gene polymorphisms with brucellosis: A systematic review with meta-analysis.Microb Pathog. 2019 Oct;135:103640. doi: 10.1016/j.micpath.2019.103640. Epub 2019 Jul 22. Microb Pathog. 2019. PMID: 31344477
-
Association of TGF-β1 Polymorphism and TGF-β1 Levels With Chronic Hepatitis C and Cirrhosis: A Systematic Review and Meta-Analysis.Cureus. 2023 Jun 29;15(6):e41157. doi: 10.7759/cureus.41157. eCollection 2023 Jun. Cureus. 2023. PMID: 37525796 Free PMC article. Review.
Cited by
-
Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.Am J Physiol Cell Physiol. 2013 Feb 1;304(3):C216-25. doi: 10.1152/ajpcell.00328.2012. Epub 2012 Dec 19. Am J Physiol Cell Physiol. 2013. PMID: 23255577 Free PMC article. Review.
-
Genetic polymorphism at codon 10 of the transforming growth factor-β1 gene in patients with alcoholic liver cirrhosis.Korean J Hepatol. 2011 Mar;17(1):37-43. doi: 10.3350/kjhep.2011.17.1.37. Korean J Hepatol. 2011. PMID: 21494076 Free PMC article. Clinical Trial.
-
Getting 'Smad' about obesity and diabetes.Nutr Diabetes. 2012 Mar 5;2(3):e29. doi: 10.1038/nutd.2012.1. Nutr Diabetes. 2012. PMID: 23449528 Free PMC article.
-
Transforming growth factor-β genetic polymorphisms on development of liver cirrhosis in a meta-analysis.Mol Biol Rep. 2013 Jan;40(1):535-43. doi: 10.1007/s11033-012-2090-1. Epub 2012 Oct 29. Mol Biol Rep. 2013. PMID: 23104471
-
Host and HBV Interactions and Their Potential Impact on Clinical Outcomes.Pathogens. 2023 Sep 8;12(9):1146. doi: 10.3390/pathogens12091146. Pathogens. 2023. PMID: 37764954 Free PMC article. Review.
References
-
- Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342:1350–1358. - PubMed
-
- Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis. 2001;21:397–416. - PubMed
-
- Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension. 1996;28:881–887. - PubMed
-
- Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014–1020. - PubMed
-
- Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000;31:828–833. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous